Optimizing Biologic Agents in Ulcerative Colitis and Crohn`s Disease
... Optimizing Biologic Agents in Ulcerative Colitis and Crohn’s Disease Abstract The goals of therapy in inflammatory bowel disease (IBD) are the induction and maintenance of clinical and biological remission. Mucosal healing is desirable to prevent complications and reduce the need for surgery, hospit ...
... Optimizing Biologic Agents in Ulcerative Colitis and Crohn’s Disease Abstract The goals of therapy in inflammatory bowel disease (IBD) are the induction and maintenance of clinical and biological remission. Mucosal healing is desirable to prevent complications and reduce the need for surgery, hospit ...
Inflammatory bowel disease
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel disease. It is important to note that not only does Crohn's disease affect the small intestine and large intestine, it can also affect the mouth, esophagus, stomach and the anus whereas ulcerative colitis primarily affects the colon and the rectum.Inflammatory bowel diseases resulted in 51,000 deaths in 2013 and 55,000 deaths in 1990.